Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 1
1971 1
1973 1
1974 2
1976 1
1979 3
1980 2
1981 2
1982 1
1983 1
1984 4
1986 2
1987 2
1988 1
1989 2
1990 3
1992 4
1993 3
1994 3
1995 2
1997 2
1998 2
1999 1
2000 4
2001 2
2002 5
2003 3
2004 2
2005 6
2006 3
2007 3
2008 2
2009 8
2010 2
2011 5
2012 5
2013 10
2014 3
2015 2
2016 10
2017 6
2018 8
2019 3
2020 5
2021 2
2022 1
2023 7
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

144 results

Results by year

Filters applied: . Clear all
Page 1
Diagnosis and management of insulinoma.
Okabayashi T, Shima Y, Sumiyoshi T, Kozuki A, Ito S, Ogawa Y, Kobayashi M, Hanazaki K. Okabayashi T, et al. World J Gastroenterol. 2013 Feb 14;19(6):829-37. doi: 10.3748/wjg.v19.i6.829. World J Gastroenterol. 2013. PMID: 23430217 Free PMC article. Review.
A high proportion of patients with insulinomas can be cured with surgery. In patients with malignant insulinomas, an aggressive medical approach, including extended pancreatic resection, liver resection, liver transplantation, chemoembolization, or radiofrequency ab …
A high proportion of patients with insulinomas can be cured with surgery. In patients with malignant insulinomas, an aggressive medic …
MANAGEMENT OF ENDOCRINE DISEASE: Pathogenesis and management of hypoglycemia.
Kittah NE, Vella A. Kittah NE, et al. Eur J Endocrinol. 2017 Jul;177(1):R37-R47. doi: 10.1530/EJE-16-1062. Epub 2017 Apr 5. Eur J Endocrinol. 2017. PMID: 28381450 Review.
The causes of endogenous hyperinsulinemic hypoglycemia include insulinoma, post-bariatric hypoglycemia and noninsulinoma pancreatogenous hypoglycemia syndrome. Autoimmune hypoglycemia syndrome is clinically and biochemically similar to insulinoma but associated with …
The causes of endogenous hyperinsulinemic hypoglycemia include insulinoma, post-bariatric hypoglycemia and noninsulinoma pancreatogen …
Insulinomas: from diagnosis to treatment. A review of the literature.
Giannis D, Moris D, Karachaliou GS, Tsilimigras DI, Karaolanis G, Papalampros A, Felekouras E. Giannis D, et al. J BUON. 2020 May-Jun;25(3):1302-1314. J BUON. 2020. PMID: 32862570 Free article. Review.
Insulinoma is the most common pancreatic neuroendocrine tumor (NET). Insulinomas are most commonly benign, well-differentiated NETs, whereas malignant neoplasms account for approximately 5-10% of all cases. Management includes conservative treatment wi …
Insulinoma is the most common pancreatic neuroendocrine tumor (NET). Insulinomas are most commonly benign, well-differentiated …
Pancreatic neuroendocrine tumors: clinical features, diagnosis and medical treatment: advances.
Ito T, Igarashi H, Jensen RT. Ito T, et al. Best Pract Res Clin Gastroenterol. 2012 Dec;26(6):737-53. doi: 10.1016/j.bpg.2012.12.003. Best Pract Res Clin Gastroenterol. 2012. PMID: 23582916 Free PMC article. Review.
Pancreatic neuroendocrine tumors (pNETs) comprise with gastrointestinal carcinoids, the main groups of gastrointestinal neuroendocrine tumors (GI-NETs). ...They differ in their pathogenesis, hormonal syndromes produced, many aspects of biological behaviour and most importa …
Pancreatic neuroendocrine tumors (pNETs) comprise with gastrointestinal carcinoids, the main groups of gastrointestinal neuroendocrin …
Treatment of symptomatic neuroendocrine tumor syndromes: recent advances and controversies.
Ito T, Lee L, Jensen RT. Ito T, et al. Expert Opin Pharmacother. 2016 Nov;17(16):2191-2205. doi: 10.1080/14656566.2016.1236916. Epub 2016 Sep 23. Expert Opin Pharmacother. 2016. PMID: 27635672 Free PMC article. Review.
All advances that controlled hormone-excess-states or facilitated-control were covered. These include new medical-therapies [serotonin-synthesis inhibitors(telotristat), Pasireotide, new agents for treating ACTHomas], increased dosing with conventional therapies (oc …
All advances that controlled hormone-excess-states or facilitated-control were covered. These include new medical-therapies [serotoni …
Endoscopic Ultrasound-guided Radiofrequency Ablation Versus Surgical Resection for Treatment of Pancreatic Insulinoma.
Crinò SF, Napoleon B, Facciorusso A, Lakhtakia S, Borbath I, Caillol F, Do-Cong Pham K, Rizzatti G, Forti E, Palazzo L, Belle A, Vilmann P, van Laethem JL, Mohamadnejad M, Godat S, Hindryckx P, Benson A, Tacelli M, De Nucci G, Binda C, Kovacevic B, Jacob H, Partelli S, Falconi M, Salvia R, Landoni L; ERASING study collaborators; Larghi A. Crinò SF, et al. Clin Gastroenterol Hepatol. 2023 Oct;21(11):2834-2843.e2. doi: 10.1016/j.cgh.2023.02.022. Epub 2023 Mar 4. Clin Gastroenterol Hepatol. 2023. PMID: 36871765
BACKGROUND & AIMS: Endoscopic ultrasound-guided radiofrequency ablation (EUS-RFA) is emerging as a safe and effective treatment for pancreatic neuroendocrine tumors. We aimed to compare EUS-RFA and surgical resection for the treatment of pancreatic insulinoma …
BACKGROUND & AIMS: Endoscopic ultrasound-guided radiofrequency ablation (EUS-RFA) is emerging as a safe and effective treatment for p …
Perspectives on the current pharmacotherapeutic strategies for management of functional neuroendocrine tumor syndromes.
Ito T, Jensen RT. Ito T, et al. Expert Opin Pharmacother. 2021 Apr;22(6):685-693. doi: 10.1080/14656566.2020.1845651. Epub 2020 Nov 11. Expert Opin Pharmacother. 2021. PMID: 33131345 Free PMC article.
This was difficult because the pharmacological-armamentarium available was limited. Recently, new therapeutic strategies have increased but it also generated controversies/uncertainties.Areas covered: The authors briefly review: established/proposed F-NENs; the rationale f …
This was difficult because the pharmacological-armamentarium available was limited. Recently, new therapeutic strategies have increas …
Diagnosis and management of neuroendocrine tumours.
Cuthbertson DJ, Shankland R, Srirajaskanthan R. Cuthbertson DJ, et al. Clin Med (Lond). 2023 Mar;23(2):119-124. doi: 10.7861/clinmed.2023-0044. Clin Med (Lond). 2023. PMID: 36958842 Free PMC article.
Clinical presentation is variable, ranging from incidental lesions detected on cross-sectional imaging, small bowel obstruction, carcinoid syndrome or other syndromic presentations (eg hypoglycaemia resulting from insulinoma) through to florid carcinoid heart disease. Diag …
Clinical presentation is variable, ranging from incidental lesions detected on cross-sectional imaging, small bowel obstruction, carcinoid s …
Pancreatic neuroendocrine tumors: contemporary diagnosis and management.
Parbhu SK, Adler DG. Parbhu SK, et al. Hosp Pract (1995). 2016 Aug;44(3):109-19. doi: 10.1080/21548331.2016.1210474. Epub 2016 Jul 18. Hosp Pract (1995). 2016. PMID: 27404266 Review.
Pancreatic neuroendocrine tumors (PNETs) are neoplasms that arise from the hormone producing cells of the islets of Langerhans, also known as pancreatic islet cells. ...These tumors are classified as 'functional' or 'non-functional' depending on whether they …
Pancreatic neuroendocrine tumors (PNETs) are neoplasms that arise from the hormone producing cells of the islets of Langerhans …
Management of Functional Pancreatic Neuroendocrine Neoplasms.
Magi L, Marasco M, Rinzivillo M, Faggiano A, Panzuto F. Magi L, et al. Curr Treat Options Oncol. 2023 Jul;24(7):725-741. doi: 10.1007/s11864-023-01085-0. Epub 2023 Apr 27. Curr Treat Options Oncol. 2023. PMID: 37103745 Free PMC article. Review.
Functional pancreatic neuroendocrine neoplasms (pNENs) are rare and heterogeneous diseases in terms of both clinical and pathological aspects. ...However, when the disease is not resectable, a broad spectrum of therapeutic options, including locoregional t …
Functional pancreatic neuroendocrine neoplasms (pNENs) are rare and heterogeneous diseases in terms of both clinical and patho …
144 results